Tigofast - 180 mg 30 tablets — Made in India — Free Deliver

Product description

Tablets "Tigofast-180" are used for the symptomatic treatment of chronic idiopathic urticaria in adults and children over 12 years of age.

Compound

The active ingredient is fexofenadine hydrochloride (one coated tablet contains fexofenadine hydrochloride 180 mg).

Excipients: microcrystalline cellulose, corn starch, sodium starch glycolate (type A), colloidal anhydrous silicon dioxide, Insta Coat Sunset Yellow film coating (ethylcellulose, hydroxypropyl methylcellulose, Sunset Yellow FCF (E 110)), talc.

Contraindications

hypersensitivity to the components of the preparation;

age up to 12 years.

Mode of application

For adults and children over 12 years of age, prescribe the preparation for chronic idiopathic urticaria - 180 mg once a day. Take orally before meals with water. The duration of treatment is determined individually, depending on the severity of the disease.

Application features

Pregnant

Fexofenadine hydrochloride should not be used during pregnancy, except in cases of extreme necessity, when the expected benefit to the mother outweighs the possible risk to the fetus.

Since fexofenadine passes into breast milk, the preparation should not be used during breastfeeding.

Children

In this dosage, the preparation should not be used in children under 12 years of age.

Drivers

Based on the pharmacodynamic profile and known side effects, it can be concluded that taking this preparation does not affect the ability to drive vehicles and perform work that requires concentration. When conducting objective studies, it was found that the preparation does not significantly affect the functions of the central nervous system (CNS). However, it is recommended to evaluate the individual response to the preparation before starting to drive or perform work that requires concentration.

Overdose

Most reports of fexofenadine hydrochloride overdose are not informative enough. Thus, dizziness, drowsiness and dry mouth have been reported.

In case of overdose, the usual measures for the removal of unabsorbed active ingredients should be applied. Symptomatic and supportive therapy is recommended. Removal of fexofenadine hydrochloride from the blood by hemodialysis is ineffective.

Side effects

From the nervous system: headache, drowsiness, dizziness.

From the gastrointestinal tract: nausea, diarrhea, epigastric cramps.

General disorders and reactions at the injection site: a feeling of increased fatigue.

From the immune system: hypersensitivity reactions, including Quincke's edema, chest tightness, shortness of breath, facial flushing and systemic anaphylactic reactions, dyspnea, hot flashes.

From the side of the psyche: insomnia, increased irritability and sleep disturbances or unusual dreams (paroniria).

From the heart: tachycardia, increased heart rate.

Skin and subcutaneous tissue disorders: rash, exanthema, urticaria, itching.

The medicinal product contains dye "Sunset Yellow FCF" (E 110), which can cause allergic reactions.

Storage conditions

Store in its original packaging at a temperature not exceeding 25 ° C, out of the reach of children.

Shelf life is 2 years.